Premium
Immunic Inc (IMUX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Avidity Private Master Fund I LP | Institution | 1 395 841 | 10,25% | US$ 20,14M | 2026-02-17 |
| Janus Henderson Group plc | Institution | 1 201 644 | 8,82% | US$ 17,34M | 2025-11-28 |
| Aberdeen Group Plc | Institution | 824 394 | 6,05% | US$ 11,90M | 2026-03-31 |
| Millennium Management LLC | Institution | 793 621 | 5,83% | US$ 11,45M | 2026-04-29 |
| BVF Partners L.P. | Institution | 765 297 | 5,62% | US$ 11,04M | 2026-03-31 |
| Integrated Core Strategies (US) LLC | Institution | 743 281 | 5,46% | US$ 10,73M | 2026-04-29 |
| Avidity Partners Management, L.P. | Institution | 669 941 | 4,92% | US$ 9,67M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 513 831 | 3,77% | US$ 7,41M | 2026-03-31 |
| Soleus Capital Master Fund, L.P. | Institution | 450 000 | 3,30% | US$ 6,49M | 2026-02-17 |
| Soleus Capital Management, L.P. | Institution | 450 000 | 3,30% | US$ 6,49M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 413 596 | 3,04% | US$ 5,97M | 2026-02-20 |
| Laurion Capital Management LP | Institution | 388 216 | 2,85% | US$ 5,60M | 2026-03-31 |
| Morgan Stanley | Institution | 328 854 | 2,41% | US$ 4,75M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 302 711 | 2,22% | US$ 4,37M | 2026-02-20 |
| Nantahala Capital Management, LLC | Institution | 250 649 | 1,84% | US$ 3,62M | 2026-03-31 |
| 683 Capital Management, LLC | Institution | 245 000 | 1,80% | US$ 3,54M | 2026-03-31 |
| Propel Bio Management, LLC | Institution | 190 584 | 1,40% | US$ 2,75M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 152 576 | 1,12% | US$ 2,20M | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 139 860 | 1,03% | US$ 2,02M | 2026-03-31 |
| Adage Capital Partners, L.P. | Institution | 139 860 | 1,03% | US$ 2,02M | 2025-06-30 |
| Soleus Capital LLC | Institution | 106 046 | 0,78% | US$ 1,53M | 2025-09-30 |
| Soleus Private Equity Fund III LP | Institution | 106 046 | 0,78% | US$ 1,53M | 2025-09-30 |
| Susquehanna International Group, LLP | Institution | 102 825 | 0,75% | US$ 1,48M | 2026-03-31 |
| Woodline Partners LP | Institution | 96 715 | 0,71% | US$ 1,40M | 2026-03-31 |
| BlackRock, Inc. | Institution | 96 423 | 0,71% | US$ 1,39M | 2026-03-31 |
| Marshall Wace LLP | Institution | 95 296 | 0,70% | US$ 1,38M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 91 916 | 0,67% | US$ 1,33M | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 74 054 | 0,54% | US$ 1,07M | 2026-03-31 |
| Ikarian Capital, LLC | Institution | 67 466 | 0,50% | US$ 973,53k | 2026-03-31 |
| Jane Street Group, LLC | Institution | 65 915 | 0,48% | US$ 951,15k | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 56 564 | 0,42% | US$ 816,22k | 2026-03-31 |
| UBS Asset Management AG | Institution | 52 279 | 0,38% | US$ 754,39k | 2026-03-31 |
| Hudson River Trading LLC | Institution | 49 339 | 0,36% | US$ 711,96k | 2026-03-31 |
| Simplify Asset Management Inc. | Institution | 43 893 | 0,32% | US$ 633,38k | 2026-03-31 |
| Biotechnology Value Trading Fund OS LP | Institution | 42 763 | 0,31% | US$ 617,07k | 2026-02-20 |
| Dr. Daniel Vitt | Initiés | 39 188 | 0,29% | US$ 565,48k | 2025-06-04 |
| Dr. Andreas Muehler | Initiés | 33 954 | 0,25% | US$ 489,96k | 2025-03-31 |
| Northern Trust Global Investments | Institution | 26 332 | 0,19% | US$ 379,97k | 2026-03-31 |
| Dr. Richard Rudick | Initiés | 23 038 | 0,17% | US$ 332,44k | 2025-06-03 |
| Hudson Bay Capital Management LP | Institution | 21 301 | 0,16% | US$ 307,37k | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
